Company Overview

So-Young International Inc. is a China-based internet company that operates a digital platform focused on the medical aesthetics and healthcare services industry. The company primarily connects consumers with medical aesthetic service providers, including private clinics, hospitals, and practitioners, through online discovery, evaluation, and transaction facilitation tools. Its core revenue drivers historically include online advertising, information services, and, increasingly, transaction-based and service-oriented offerings within the medical aesthetics value chain.

Founded in 2013, So-Young evolved from an online community centered on cosmetic surgery reviews into a broader medical aesthetics platform integrating content, marketplace services, and digital tools for providers. The company positions itself as a data-driven intermediary with extensive consumer-generated content and practitioner information, aiming to enhance transparency, trust, and efficiency in China’s fragmented aesthetic medical services market.

Business Operations

So-Young’s operations are organized around several core business activities, including its So-Young Platform consumer marketplace, information and content services, and medical service enablement solutions for providers. Revenue has historically been generated through online marketing services sold to clinics and practitioners, commissions from booked procedures, and technology-enabled services that support clinic operations, customer acquisition, and patient management.

The company operates primarily in Mainland China, with no material revenue contribution from overseas markets disclosed in public filings. It controls proprietary data assets related to consumer behavior and practitioner performance, as well as mobile applications and online platforms that serve both consumers and service providers. Public disclosures indicate that So-Young operates through wholly owned subsidiaries in China, structured to comply with local regulatory requirements applicable to internet and healthcare-related businesses.

Strategic Position & Investments

Strategically, So-Young has focused on transitioning from an advertising-heavy model toward deeper participation in the medical aesthetics value chain. Growth initiatives have included expanding transaction-based services, developing clinic management and supply-chain related tools, and selectively investing in or supporting downstream medical service providers to strengthen ecosystem integration.

The company has disclosed investments in medical aesthetic clinics and service providers intended to improve service quality control and capture incremental value beyond platform fees. It has also emphasized the use of data analytics, artificial intelligence, and digital health technologies to improve matching efficiency, pricing transparency, and post-procedure engagement. Public information indicates that while these initiatives are ongoing, their long-term financial impact remains subject to execution and regulatory conditions in China’s healthcare sector.

Geographic Footprint

So-Young’s business activities are concentrated in Mainland China, where it serves users across major urban centers with high demand for medical aesthetic services. The company is headquartered in Beijing, which functions as its primary operational, management, and strategic center.

While the platform may be accessible to users outside China, public disclosures do not indicate material international operations, revenues, or physical infrastructure outside the Chinese market. Its geographic influence is therefore primarily domestic, aligned with regulatory oversight and consumer demand patterns within China.

Leadership & Governance

So-Young was founded by Jin Xing � Founder and Chief Executive Officer, who has led the company since its inception and has been central to its strategic vision of increasing transparency and efficiency in the medical aesthetics market. The company is publicly listed in the United States and is governed by a board of directors that includes executive and independent members, consistent with U.S. public company requirements.

Key members of the leadership team include:

• Jin Xing � Founder and Chief Executive Officer
• Daniel (Yu) Chen � Chief Financial Officer
• Amy Yi Zhou � President
• Wei Zhang � Chief Technology Officer

Management has publicly articulated a strategy focused on long-term ecosystem development, regulatory compliance, and sustainable monetization through technology-enabled healthcare services rather than purely traffic-driven advertising models.